Get startedLog in
    Picture of Dermapharm Holding SE logo

    DMP — Dermapharm Holding SE News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareBalancedMid CapNeutral
    All News

    Brief: Dermapharm Confirms 2023 Outlook

    Picture of Dermapharm Holding SE logoDermapharm Holding SE
    15/05/2023 06:38
    May 15 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * CONFIRMS OUTLOOK FOR 2023 OVERALL, EXPECTS CONSOLIDATED
REVENUE
OF EUR 1,080-1,110 MILLION AND ADJUSTED EBITDA OF EUR 300-310
MILLION
    * HERBAL EXTRACTS UNIT Q1 REVENUE OF EUR 91.3 MILLION
(PREVIOUS
YEAR: EUR 25.6 MILLION), DRIVEN BY ADDITIONAL CONTRIBUTIONS FROM
ARKOPHARMA GROUP

Source text for Eikon:  ID:nEQ9jtD9Ta 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Dermapharm Holding SE

    See all news